Allygen Biosciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $44.7M

  • Investors
  • 7

Allygen Biosciences General Information

Description

Developer of targeted conjugate therapeutics designed for the treatment of solid tumors. The company utilizes a proprietary smart tumor microenvironment activated release technology to design therapies that are selectively activated within tumor sites, enabling the healthcare industry to access dual-targeting molecules that combine chemotherapy and immunotherapy mechanisms for enhanced efficacy and reduced toxicity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 19, Lane 2777, Jinxiu East Road
  • Pudong New Area
  • Shanghai, 201206
  • China
+86 138
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Number 19, Lane 2777, Jinxiu East Road
  • Pudong New Area
  • Shanghai, 201206
  • China
+86 138

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allygen Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC (Series A) 13-Oct-2026 $44.7M Completed Generating Revenue
To view Allygen Biosciences’s complete valuation and funding history, request access »

Allygen Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allygen Biosciences Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing State-owned Capital Operation and Management Government Minority
Huagai Capital Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
Sherpa Healthcare Partners Growth/Expansion Minority
TigerYeah Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Allygen Biosciences FAQs

  • When was Allygen Biosciences founded?

    Allygen Biosciences was founded in 2017.

  • Where is Allygen Biosciences headquartered?

    Allygen Biosciences is headquartered in Shanghai, China.

  • What is the size of Allygen Biosciences?

    Allygen Biosciences has 50 total employees.

  • What industry is Allygen Biosciences in?

    Allygen Biosciences’s primary industry is Drug Discovery.

  • Is Allygen Biosciences a private or public company?

    Allygen Biosciences is a Private company.

  • What is Allygen Biosciences’s current revenue?

    The current revenue for Allygen Biosciences is .

  • How much funding has Allygen Biosciences raised over time?

    Allygen Biosciences has raised $44.7M.

  • Who are Allygen Biosciences’s investors?

    Beijing State-owned Capital Operation and Management, Huagai Capital, Qiming Venture Partners, Sherpa Healthcare Partners, and TigerYeah Capital are 5 of 7 investors who have invested in Allygen Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process